HK1124339A1 - 具有激動劑或拮抗劑激素活性的 -酮- β-芳基甾族化合物及其衍生物 - Google Patents
具有激動劑或拮抗劑激素活性的 -酮- β-芳基甾族化合物及其衍生物Info
- Publication number
- HK1124339A1 HK1124339A1 HK09103798.9A HK09103798A HK1124339A1 HK 1124339 A1 HK1124339 A1 HK 1124339A1 HK 09103798 A HK09103798 A HK 09103798A HK 1124339 A1 HK1124339 A1 HK 1124339A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- arylsteroids
- 11beta
- keto
- agonist
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
- C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Epidemiology (AREA)
- Pregnancy & Childbirth (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/035,949 US6020328A (en) | 1998-03-06 | 1998-03-06 | 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1124339A1 true HK1124339A1 (zh) | 2009-07-10 |
Family
ID=21885722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09103798.9A HK1124339A1 (zh) | 1998-03-06 | 2001-06-20 | 具有激動劑或拮抗劑激素活性的 -酮- β-芳基甾族化合物及其衍生物 |
Country Status (13)
Country | Link |
---|---|
US (1) | US6020328A (zh) |
EP (2) | EP1060186A4 (zh) |
JP (4) | JP4563578B2 (zh) |
KR (1) | KR20010041667A (zh) |
CN (1) | CN1298409A (zh) |
AU (1) | AU767660B2 (zh) |
BR (1) | BR9908598A (zh) |
CA (1) | CA2322862C (zh) |
ES (1) | ES2488095T3 (zh) |
HK (1) | HK1124339A1 (zh) |
IL (1) | IL138280A0 (zh) |
MX (1) | MXPA00008738A (zh) |
WO (1) | WO1999045022A1 (zh) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6407082B1 (en) * | 1996-09-13 | 2002-06-18 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a vitamin D compound |
US6861415B2 (en) * | 1996-05-01 | 2005-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | 21-substituted progesterone derivatives as new antiprogestational agents |
US6900193B1 (en) * | 1996-05-01 | 2005-05-31 | The United States Of America As Represented By The Department Of Health And Human Services | Structural modification of 19-norprogesterone I: 17-α-substituted-11-β-substituted-4-aryl and 21-substituted 19-norpregnadienedione as new antiprogestational agents |
US6028064A (en) | 1996-09-13 | 2000-02-22 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of progestin products |
US6511970B1 (en) | 1996-09-13 | 2003-01-28 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium |
US6034074A (en) | 1996-09-13 | 2000-03-07 | New Life Pharmaceuticals Inc. | Prevention of ovarian cancer by administration of a Vitamin D compound |
US6765002B2 (en) | 2000-03-21 | 2004-07-20 | Gustavo Rodriguez | Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium |
US6262042B1 (en) * | 1998-05-29 | 2001-07-17 | Research Triangle Institute | 17β-amino and hydroxylamino-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US6172052B1 (en) | 1998-12-04 | 2001-01-09 | Research Triangle Institute | 17β-acyl-17α-propynyl-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
US6740645B1 (en) * | 1999-09-03 | 2004-05-25 | Research Triangle Institute | 17β-acyl-17α-propynyl-11β-(cyclic amino) aryl steroids and their derivatives having antagonist hormonal properties |
ES2307604T3 (es) * | 2000-03-17 | 2008-12-01 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | 19-norpregnadienodiona 17-a sustituidos, 11-b-sustituido-4-arilo y 21-sustituidos como nuevos agentes antiprogestacionales. |
US20010044431A1 (en) * | 2000-03-21 | 2001-11-22 | Rodriguez Gustavo C. | Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium |
ES2212912B1 (es) * | 2003-01-22 | 2005-10-01 | Crystal Pharma, S.A. | Procedimiento para la obtencion de 17alfa-acetoxi-11beta-(4-n,n-dimetilaminofenil)-19-norpregna-4,9-dien-3,20-diona. |
AU2004217988C1 (en) * | 2003-02-28 | 2010-06-03 | Southwest Foundation For Biomedical Research | Method for preparing 17 alpha-acetoxy-11beta-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione, intermediates thereof, and methods for the preparation of such intermediates |
US20060247452A1 (en) * | 2004-01-21 | 2006-11-02 | Guisasola Luis Octavio S | Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione |
TW200531977A (en) * | 2004-03-25 | 2005-10-01 | Akzo Nobel Nv | Progesterone receptor modulators |
EP1862468A1 (de) * | 2006-06-02 | 2007-12-05 | Bayer Schering Pharma Aktiengesellschaft | Kristallines 11beta-(4-Acetylphenyl)-20,20,21,21,21-pentafluor-17-hydroxy-19-nor-17alpha-pregna-4,9-dien-3-on |
US9517240B2 (en) | 2006-09-26 | 2016-12-13 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
WO2008039482A2 (en) * | 2006-09-26 | 2008-04-03 | The Regents Of The University Of California | Methods and compositions for cancer prevention and treatment |
HUE051484T2 (hu) * | 2006-10-24 | 2021-03-01 | Allergan Pharmaceuticals Int Ltd | Készítmények és eljárások az endometriális proliferációk elnyomására |
BRPI0806572A2 (pt) * | 2007-01-17 | 2014-05-06 | Repros Therapeutics Inc | Composição e método de produção de efeito antiprogestacional, de indução menstrual, de tratamento de endometriose, da dismenorreia, de tumores dependentes de hormônio endócrino, de meningiomas, de fibriomas uterinos, de inibição da proliferação endometrial uterina, de indução de trabalho de parto e de contracepção. |
TWI477276B (zh) | 2008-04-28 | 2015-03-21 | Repros Therapeutics Inc | 抗黃體素給藥方案 |
DE102009034366A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034368A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034367A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102009034362A1 (de) | 2009-07-20 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102009034526A1 (de) | 2009-07-21 | 2011-02-10 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten |
DE102009034525A1 (de) | 2009-07-21 | 2011-01-27 | Bayer Schering Pharma Aktiengesellschaft | 17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten |
DE102010007722A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
DE102010007719A1 (de) | 2010-02-10 | 2011-08-11 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Progesteronrezeptorantagonisten |
CN102241722B (zh) * | 2010-05-12 | 2015-11-25 | 杭州容立医药科技有限公司 | 一种合成孕酮受体调节剂优力司特的纯化方法 |
CN102372760A (zh) * | 2010-08-12 | 2012-03-14 | 杭州容立医药科技有限公司 | 一种合成孕酮受体调节剂优力司特的合成方法 |
UA113283C2 (xx) | 2010-12-23 | 2017-01-10 | 19-норстероїди і їх застосування для лікування прогестеронзалежних станів | |
CN102516345B (zh) * | 2011-11-01 | 2014-11-26 | 上海优拓医药科技有限公司 | 醋酸乌利司他及其关键中间体的制备方法 |
NZ702467A (en) | 2012-05-31 | 2016-07-29 | Repros Therapeutics Inc | Formulations and methods for vaginal delivery of antiprogestins |
ES2688821T3 (es) | 2012-11-02 | 2018-11-07 | Repros Therapeutics Inc. | Métodos y composiciones para tratar afecciones dependientes de la progesterona |
CN103145787B (zh) * | 2012-12-25 | 2017-02-22 | 常州市亚邦医药研究所有限公司 | 制备醋酸优力司特关键中间体的新方法 |
US9096641B2 (en) * | 2013-06-05 | 2015-08-04 | Evestra, Inc. | Imidazolyl progesterone antagonists |
HU230319B1 (hu) | 2013-10-01 | 2016-01-28 | Richter Gedeon Nyrt. | Ipari eljárás szteroid hatóanyagok előállítására |
HU230397B1 (hu) | 2013-11-25 | 2016-04-28 | Richter Gedeon Nyrt. | Eljárás (11b,17a)-17-acetoxi-11-metil-19-norpregn-4-én-3,20-dion előállítására |
US9850273B2 (en) | 2014-12-03 | 2017-12-26 | Evestra, Inc. | Combination of estrogens plus antiprogestins with significant partial agonistic effect as an effective treatment of menopausal symptoms and for prevention of the occurrence of breast cancer |
CN110028543B (zh) * | 2018-01-11 | 2024-04-12 | 上海汇伦医药股份有限公司 | 一种醋酸优力司特的制备方法 |
CN109575098B (zh) * | 2019-01-18 | 2021-01-01 | 湖南成大生物科技有限公司 | 诺孕美特的合成方法 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE290198C (zh) * | ||||
DE289539C (zh) * | ||||
DE287510C (zh) * | ||||
US3547912A (en) * | 1968-07-29 | 1970-12-15 | American Home Prod | Derivatives of 2h-pyran-3(6h)-ones and preparation thereof |
ZA8231B (en) * | 1981-01-09 | 1982-11-24 | Roussel Uclaf | New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained |
FR2522328B1 (fr) | 1982-03-01 | 1986-02-14 | Roussel Uclaf | Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments |
DE3461090D1 (en) * | 1983-02-18 | 1986-12-04 | Schering Ag | 11-beta-aryl-estradienes, process for their preparation and pharmaceutical compositions containing them |
DE3306121A1 (de) * | 1983-02-18 | 1984-09-06 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11ss-aryl-spirolaktone in der steroidreihe, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische praeparate |
US4512986A (en) | 1983-07-26 | 1985-04-23 | Research Triangle Institute | Progrestationally active steroids |
DE3347126A1 (de) * | 1983-12-22 | 1985-07-11 | Schering AG, 1000 Berlin und 4709 Bergkamen | 11ss-aryl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
AU580843B2 (en) * | 1985-02-07 | 1989-02-02 | Schering Aktiengesellschaft | 11``-phenyl-gonanes, their manufacture and pharmaceutical preparations containing them |
DE3506785A1 (de) * | 1985-02-22 | 1986-08-28 | Schering AG, Berlin und Bergkamen, 1000 Berlin | 11ss-n,n-dimethylaminophenyl-estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
FR2596395B1 (fr) * | 1986-03-26 | 1989-05-26 | Roussel Uclaf | Nouveaux steroides comportant un cycle spirannique en position 17, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
FR2598421B1 (fr) * | 1986-05-06 | 1988-08-19 | Roussel Uclaf | Nouveaux produits 19-nor ou 19-nor d-homo steroides substitues en position 11b par un radical phenyle portant un radical alkynyle, leur procede de preparation, leur application comme medicaments et les compositions les renfermant |
DE3625315A1 (de) * | 1986-07-25 | 1988-01-28 | Schering Ag | 11ss-(4-isopropenylphenyl)-estra-4,9-diene, deren herstellung und diese enthaltende pharmazeutische praeparate |
US4774236A (en) * | 1986-09-17 | 1988-09-27 | Research Triangle Institute | 17α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and pharmaceutical compositions containing them |
US4861763A (en) * | 1986-09-17 | 1989-08-29 | Research Triangle Institute | 17 α-(substituted-methyl)-17β-hydroxy/esterified hydroxy steroids and their progestational use |
IE60780B1 (en) * | 1987-01-23 | 1994-08-10 | Akzo Nv | New 11-aryl steroid derivatives |
DE3702383A1 (de) * | 1987-01-23 | 1988-08-04 | Schering Ag | 11ss-alkinylestrene und -estradiene, deren herstellung und diese enthaltende pharmazeutische praeparate |
FR2610933B1 (fr) * | 1987-02-18 | 1989-06-09 | Roussel Uclaf | Nouveaux 19-nor steroides substitues en position 7, leur preparation, leur application comme medicaments, les compositions pharmaceutiques les renfermant |
ATE69820T1 (de) * | 1987-04-24 | 1991-12-15 | Akzo Nv | 11-arylestranderivate und 11-arylpregnanderivate. |
FR2618783B1 (fr) * | 1987-07-30 | 1991-02-01 | Roussel Uclaf | Nouveaux 17-aryle steroides, leurs procedes et des intermediaires de preparation comme medicaments et les compositions pharmaceutiques les renfermant |
FR2620707B1 (fr) * | 1987-09-18 | 1989-12-08 | Roussel Uclaf | Nouveaux steroides comportant un cycle spirannique a 3, 4 ou 6 chainons en position 17, leur procede et des intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant |
DE3878198T2 (de) * | 1987-12-12 | 1993-06-24 | Akzo Nv | 11-arylsteroid-derivate. |
US4954490A (en) * | 1988-06-23 | 1990-09-04 | Research Triangle Institute | 11 β-substituted progesterone analogs |
DE3822770A1 (de) * | 1988-07-01 | 1990-01-04 | Schering Ag | 13-alkyl-11ss-phenylgonane |
DE3921059A1 (de) * | 1989-06-23 | 1991-01-10 | Schering Ag | 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel |
WO1991001958A2 (de) * | 1989-08-04 | 1991-02-21 | Schering Aktiengesellschaft Berlin Und Bergkamen | 11β-ARYL-GONA-4,9-DIEN-3-ONE |
DD290198A5 (de) | 1989-09-18 | 1991-05-23 | Zi Fuer Mikrobiologie Und Experimentelle Therapie Jena,De | Verfahren zur herstellung von 11 beta-arylsubstituierten estra-4,9-dien-3-on-17(s)-spiro-1'-cyclohexan-2'-onen und 11 beta-arylsubstituierten estra-4,9-dien-3-on-17(s)-spiro-1'-cyclohexan-2'-olen sowie deren derivate |
DE4042005A1 (de) * | 1990-12-22 | 1992-06-25 | Schering Ag | D-homo-(16-en)-11(beta)-aryl-4-estrene |
ZA929315B (en) * | 1991-12-20 | 1993-05-24 | Akzo Nv | 17-spirofuran-3'-ylidene steroids. |
FR2688004A1 (fr) * | 1992-02-27 | 1993-09-03 | Roussel Uclaf | Nouveaux sterouides comportant en position 17 un radical methylene lactone, leur procede et des intermediaires de preparation, leur application comme medicaments. |
MX9301121A (es) * | 1992-03-02 | 1993-09-01 | Schering Ag | Metodo y equipo para la contracepcion oral y regulacion de la menstruacion con estrogeno/progestina/aniprogestina. |
WO1993021926A1 (en) * | 1992-05-06 | 1993-11-11 | Medical College Of Hampton Roads | Minimizing progestin associated breakthrough bleeding |
CA2100514C (en) * | 1992-07-29 | 2005-03-29 | Johannes A. M. Hamersma | 17-spiromethylene steroids |
US5929262A (en) * | 1995-03-30 | 1999-07-27 | The United States Of America As Represented By The Department Of Health And Human Services | Method for preparing 17α-acetoxy-11β-(4-N, N-dimethylaminophyl)-19-Norpregna-4,9-diene-3, 20-dione, intermediates useful in the method, and methods for the preparation of such intermediates |
JP3620893B2 (ja) | 1995-07-21 | 2005-02-16 | 日本パーカライジング株式会社 | アルミニウム含有金属用表面処理組成物及び表面処理方法 |
US6861415B2 (en) * | 1996-05-01 | 2005-03-01 | The United States Of America As Represented By The Department Of Health And Human Services | 21-substituted progesterone derivatives as new antiprogestational agents |
-
1998
- 1998-03-06 US US09/035,949 patent/US6020328A/en not_active Expired - Lifetime
-
1999
- 1999-03-05 IL IL13828099A patent/IL138280A0/xx unknown
- 1999-03-05 JP JP2000534564A patent/JP4563578B2/ja not_active Expired - Fee Related
- 1999-03-05 CN CN99805414A patent/CN1298409A/zh active Pending
- 1999-03-05 WO PCT/US1999/003732 patent/WO1999045022A1/en not_active Application Discontinuation
- 1999-03-05 MX MXPA00008738A patent/MXPA00008738A/es unknown
- 1999-03-05 KR KR1020007009874A patent/KR20010041667A/ko not_active Application Discontinuation
- 1999-03-05 CA CA002322862A patent/CA2322862C/en not_active Expired - Lifetime
- 1999-03-05 EP EP99909531A patent/EP1060186A4/en not_active Ceased
- 1999-03-05 BR BR9908598-4A patent/BR9908598A/pt not_active Application Discontinuation
- 1999-03-05 ES ES08101671.9T patent/ES2488095T3/es not_active Expired - Lifetime
- 1999-03-05 AU AU28715/99A patent/AU767660B2/en not_active Expired
- 1999-03-05 EP EP08101671.9A patent/EP2039701B1/en not_active Expired - Lifetime
-
2001
- 2001-06-20 HK HK09103798.9A patent/HK1124339A1/zh unknown
-
2010
- 2010-02-25 JP JP2010040245A patent/JP5394950B2/ja not_active Expired - Fee Related
- 2010-02-25 JP JP2010040246A patent/JP5419750B2/ja not_active Expired - Fee Related
-
2013
- 2013-09-17 JP JP2013191496A patent/JP5770235B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP5770235B2 (ja) | 2015-08-26 |
WO1999045022A1 (en) | 1999-09-10 |
JP4563578B2 (ja) | 2010-10-13 |
JP2010120972A (ja) | 2010-06-03 |
AU2871599A (en) | 1999-09-20 |
AU767660B2 (en) | 2003-11-20 |
EP2039701A3 (en) | 2013-02-27 |
KR20010041667A (ko) | 2001-05-25 |
CA2322862A1 (en) | 1999-09-10 |
CN1298409A (zh) | 2001-06-06 |
EP1060186A4 (en) | 2005-05-04 |
JP2002505334A (ja) | 2002-02-19 |
JP2010120973A (ja) | 2010-06-03 |
JP5394950B2 (ja) | 2014-01-22 |
IL138280A0 (en) | 2001-10-31 |
MXPA00008738A (es) | 2004-05-21 |
ES2488095T3 (es) | 2014-08-26 |
EP1060186A1 (en) | 2000-12-20 |
EP2039701A2 (en) | 2009-03-25 |
JP5419750B2 (ja) | 2014-02-19 |
US6020328A (en) | 2000-02-01 |
EP2039701B1 (en) | 2014-04-23 |
JP2013253106A (ja) | 2013-12-19 |
BR9908598A (pt) | 2001-10-02 |
CA2322862C (en) | 2008-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1124339A1 (zh) | 具有激動劑或拮抗劑激素活性的 -酮- β-芳基甾族化合物及其衍生物 | |
HK1042084B (zh) | 取代的苯並咪唑及其製備和用途 | |
HRP20060251B1 (hr) | Supstituirani oksazolidinoni i njihova uporaba | |
HUS1300054I1 (hu) | Herbicid hatású 3-hidroxi-4-aril-5-oxo-pirazolin-származékok és alkalmazásuk | |
SG85628A1 (en) | Compound and its use | |
PL344407A1 (en) | Il-2 selective agonists and antagonists | |
HUP0102152A3 (en) | Nucleosid and oligo nucleotid analogues having bicyclic sugar derivative | |
EP1115389A4 (en) | ANTAGONISTS AND AGONISTS OF FRUCTOSAMINE OXIDASE | |
HUP0203896A3 (en) | Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof | |
HUP0103636A3 (en) | 2-methyl-thieno-benzodiazepine formulation and its use | |
EP1056455A4 (en) | EPIMORPHIN COMPOUND AND USE OF THE SAME | |
HU0001396D0 (en) | 3-amino-3-arylpropan-1-al derivatives and their use | |
HUP0103473A3 (en) | Phosphoglycolipid and methods for its use | |
PL332616A1 (en) | Hydoxymethylhexanones as odorising and savourising agents | |
GB2342863B (en) | Probe | |
HUP0003063A3 (en) | Synergetic fungicidal composition and its use | |
HUP0104723A3 (en) | New 2-aminothiazol-fused 2-aminoindans and 2-aminotetralins and their use | |
HUP0104414A3 (en) | Synergetic fungicidal mixture comprising carbamate derivatives and its use | |
GB9820014D0 (en) | Receptor antagonists and uses thereof | |
GB9701374D0 (en) | Purinergic agonists and antagonists | |
EP1229913A4 (en) | SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES | |
HUP0101996A3 (en) | Synergetic fungicidal mixture and its use | |
IL134774A0 (en) | A COMBINATION OF A SELECTIVE 5-HT1A ANTAGONIST AND A SELECTIVE h5-HT1B ANTAGONIST OR PARTIAL AGONIST | |
HUP0004838A3 (en) | Synergetic fungicidal combination comprising benzyl-ether derivative and n-acetonyl-benzamide derivative and its use | |
IL137428A0 (en) | Estrogen agonists and antagonists for multiple indications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AM | Amended specification (according sect 146 of patent law) |
Free format text: CORRECTION OF THE CHINESE TRANSLATION OF ABSTRACT AND CHINESE TITLE OF INVENTION FROM Effective date: 20150604 |